Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.54
Delayed Data
As of 9:49am ET
 +0.05 / +2.01%
Today’s Change
0.88
Today|||52-Week Range
3.68
+159.24%
Year-to-Date

Today’s Trading

Previous close2.49
Today’s open2.49
Day’s range2.49 - 2.64
Volume89,908
Average volume (3 months)449,988
Market cap$85.9M
Data as of 9:49am ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+32.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book25.98

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.01-0.51%
TRILTrillium Therapeutic...0.000.00%
VRMLVermillion Inc-0.00-0.12%
IDXGInterpace Diagnostic...+0.02+2.09%
Data as of 10:02am ET, 12/14/2017

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts